Share This Page
Suppliers and packagers for generic pharmaceutical drug: florbetaben f-18
✉ Email this page to a colleague
florbetaben f-18
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Lantheus | NEURACEQ | florbetaben f-18 | SOLUTION;INTRAVENOUS | 204677 | NDA | Lantheus Biosciences Ltd., a Lantheus Company | 54828-001-50 | 1 VIAL, MULTI-DOSE in 1 CONTAINER (54828-001-50) / 50 mL in 1 VIAL, MULTI-DOSE | 2014-03-20 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
FLORBETABEN F-18 Suppliers: Who Manufactures, Distributes, and Supplies the F-18 Imaging Agent?
Executive summary: Florbetaben F-18 supply in the US and EU is constrained by (1) availability of the fluorine-18 production isotope, (2) tracer-specific GMP radiochemistry capacity, and (3) regulatory authorization pathways for each national market. Commercial supply is typically handled through a small set of specialty radiopharmaceutical manufacturers and authorized distributors rather than broad generic pharma supply chains. Procurement is usually executed via direct orders to the radiopharmacy/wholesaler authorized for sale and shipment in the target geography.
This page covers supplier categories and the operational supply chain that determines real-world availability of FLORBETABEN F-18.
What companies supply FLORBETABEN F-18 in the US and Europe?
Featured snippet answer: FLORBETABEN F-18 is supplied via authorized radiopharmaceutical manufacturers and distributors in each market, with ordering typically routed through the authorized distributor or licensed nuclear medicine radiopharmacy channels for the destination country.
US market supply pattern
In the US, FLORBETABEN F-18 is supplied through:
- Manufacturer or marketing authorization holder channels for the radiotracer
- Nuclear medicine distribution networks (licensed distributors and radiopharmacies)
- Radiopharmacy compounding/labeling constraints driven by short half-life logistics (F-18)
Practical implication: Supplier selection is less about “multiple equivalent manufacturers” and more about:
- whether the distributor can ship to the site within time-temperature constraints,
- whether the distributor is active for the exact strength/configuration used in practice, and
- whether the distributor supports cold-chain and same-day delivery workflows.
EU market supply pattern
In the EU, supply depends on:
- national authorization of the product and its distribution,
- local radiopharmacy infrastructure,
- procurement through country-level wholesalers and authorized radiopharmacies.
Practical implication: “European supplier list” is usually fragmented by country. The same branded tracer may show different distribution partners per member state.
How does fluorine-18 isotope availability affect FLORBETABEN F-18 suppliers?
Featured snippet answer: F-18 supply bottlenecks cascade into Florbetaben F-18 availability because tracer production is scheduled against the availability of fluorine-18 produced by cyclotrons and irradiations.
Supply chain dependencies
- Cyclotron irradiations and isotope schedule
- Radiopharmaceutical manufacturers plan tracer runs to match irradiations and purification windows.
- Radiochemistry and QC release capacity
- Multiple hand-offs happen between isotope receipt, tracer synthesis, and release testing.
- GMP radiopharmacy release and distribution
- Short half-life drives same-day processing and dispatch.
Resulting commercial reality
- Even where multiple distribution firms exist, tracer supply can be effectively constrained by isotope and manufacturing batch release windows.
- Procurement schedules often need to align with declared production runs.
Which entities provide distributor and radiopharmacy logistics for FLORBETABEN F-18?
Featured snippet answer: Authorized distributors and licensed radiopharmacies provide the “last-mile” delivery required for F-18 products, with shipment coordinated to preserve tracer potency and meet release/handling requirements.
Common roles in the supply chain
- Marketing authorization holder or radiopharmaceutical manufacturer: produces and releases the drug product.
- Authorized wholesaler/distributor: holds distribution authorization and arranges shipment.
- Nuclear medicine centers and radiopharmacies: receive, store, and administer under local licensing.
- Hospital-based nuclear medicine supply channels: frequently receive through distribution partners rather than direct isotopic logistics.
Procurement workflow
- Sites typically place orders with the distributor that can service their delivery region and schedule.
- Radiopharmacy centers may request tracer from authorized channels rather than independent sources.
What patents and regulatory approvals affect FLORBETABEN F-18 sourcing and “generic” alternatives?
Featured snippet answer: FLORBETABEN F-18 is not generally sourced as “generic” product across geographies in the way conventional small-molecule drugs are. Regulatory and technical constraints keep supply tied to authorized tracer products and their distribution partners.
Why “generic supplier” does not map cleanly to tracers
Radiotracers face:
- tight batch release testing,
- isotope-dependent manufacturing,
- short shelf-life constraints,
- regulatory product-specific authorizations.
Commercial effect
- A “supplier list” often reflects licensed distribution capacity more than patent-expired multiple-generic production.
What product forms and handling constraints determine which suppliers can deliver FLORBETABEN F-18?
Featured snippet answer: Only suppliers with F-18 radiotracer handling capability and same-day distribution infrastructure can consistently service end users.
Handling constraints
- Time-to-delivery after calibration
- Transportation conditions for radiopharmaceuticals
- Lot release documentation and chain-of-custody processes
Site-level constraints
- Availability of appropriate nuclear medicine administration workflows
- Receipt hours and emergency delivery protocols during short half-life periods
What is the Orange Book status of FLORBETABEN F-18 and how does it influence supply?
Featured snippet answer: FLORBETABEN F-18 is a radiopharmaceutical imaging agent and is not typically evaluated in the same way as oral small-molecule products for “generic entry” supply competition.
Supply influence mechanism
- Where a product is tied to specific marketing authorization and tracer-specific manufacturing, supply is dominated by authorized radiopharmaceutical players and their distributors rather than rapid generic replacement.
How many supplier options exist for FLORBETABEN F-18 and what are the main barriers?
Featured snippet answer: Supplier options are limited by manufacturing capacity and authorized distribution networks, with primary barriers tied to isotope scheduling, GMP release testing, and short half-life logistics.
Key barriers
- Cyclotron isotope availability (F-18)
- Radiochemistry capacity and staffing for tracer synthesis
- QC release capacity (impurities, identity, radiochemical purity)
- Authorized distribution and radiopharmacy receipt capability
- Regulatory authorization for distribution in each country
Supplier comparison: what to evaluate when choosing vendors for FLORBETABEN F-18?
Featured snippet answer: Evaluate delivery reliability and regulatory authorization, not only price.
Vendor selection checklist
- Distribution authorization for the destination geography
- Ability to meet same-day shipping windows
- Lot release documentation and traceability support
- Consistency of formulation strength and container configuration
- Historical delivery performance during isotope-constrained periods
Key Takeaways
- FLORBETABEN F-18 supply is governed by F-18 isotope scheduling, tracer GMP radiochemistry capacity, and short half-life logistics.
- In the US and EU, “suppliers” are usually authorized radiopharmaceutical manufacturers and licensed distributors/radiopharmacies rather than a large field of competing generic manufacturers.
- Real-world sourcing depends on whether a distributor can deliver reliably to the specific site within the radiotracer’s operational time window.
- “Supplier lists” are best represented by market-specific authorized distribution channels, which vary by country.
FAQs
- Who can legally distribute FLORBETABEN F-18? Licensed radiopharmaceutical distributors/wholesalers and authorized radiopharmacies under destination-country rules.
- Why does FLORBETABEN F-18 sometimes face shortages? Fluorine-18 production scheduling, tracer manufacturing batch release capacity, and same-day logistics constraints.
- Can hospitals source FLORBETABEN F-18 directly from isotope suppliers? Generally no; supply is routed through authorized radiopharmaceutical product and licensed distribution channels.
- Is there a generic version of FLORBETABEN F-18 available from multiple suppliers? Supply is typically constrained to authorized tracer products and their distributors; generic competition is not analogous to standard pharmaceuticals.
- How should users manage ordering for FLORBETABEN F-18 to ensure availability? Align orders with distributor production and dispatch schedules and confirm lot release/shipping capability for the delivery site.
References
- FDA. “Drug Shortages.” U.S. Food and Drug Administration. (Accessed 2026-05-26).
- European Medicines Agency (EMA). “Medicine information: florbetaben F 18.” (Accessed 2026-05-26).
- U.S. National Library of Medicine. ClinicalTrials.gov and related radiopharmaceutical references for florbetaben F-18 supply context. (Accessed 2026-05-26).
More… ↓
